Covered recipient · General Payments record
JAMIE L BUCK
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$1,473.09
- Reported across 87 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $335.46 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Hologic Sales and Service, LLC | $90.32 | 2 |
| Amgen Inc. | $44.33 | 3 |
| Exeltis, USA Inc. | $36.01 | 2 |
| Sumitomo Pharma America, Inc. | $35.71 | 2 |
| Axonics Modulation Technologies, Inc. | $31.56 | 2 |
| ABBVIE INC. | $30.53 | 2 |
| Astellas Pharma US Inc | $28.76 | 2 |
| Daiichi Sankyo Inc. | $22.03 | 1 |
| PFIZER INC. | $16.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.18 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103385799 | CMS |
| ABBVIE INC. | $16.35 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103385801 | CMS |
| Amgen Inc. | $13.99 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111538665 | CMS |
| Amgen Inc. | $15.58 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111538667 | CMS |
| Amgen Inc. | $14.76 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111538669 | CMS |
| Astellas Pharma US Inc | $13.71 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139299754 | CMS |
| Astellas Pharma US Inc | $15.05 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139372815 | CMS |
| Axonics, Inc. | $15.78 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142390198 | CMS |
| Axonics, Inc. | $15.78 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142390250 | CMS |
| Daiichi Sankyo Inc. | $22.03 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089404098 | CMS |
| Exeltis, USA Inc. | $15.54 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149989009 | CMS |
| Exeltis, USA Inc. | $20.47 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149989014 | CMS |
| Hologic Sales and Service, LLC | $13.98 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084905818 | CMS |
| Hologic Sales and Service, LLC | $76.34 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084905842 | CMS |
| PFIZER INC. | $16.21 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131635349 | CMS |
| Sumitomo Pharma America, Inc. | $14.09 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148833119 | CMS |
| Sumitomo Pharma America, Inc. | $21.62 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148833121 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.